0
0
8/28/23 at 2:05pm
Organization
Moneycontrol
Author
Moneycontrol News
35 words
0
Comments
Shanghvi said that the company’s businesses are well-positioned, and it expects high-single-digit consolidated topline growth for FY24
You are the first to view
https://www.moneycontrol.com/news/business/markets/sun-pharma-to-increase-rd-spending-in-specialty-products-md-dilip-shanghvi-11272831.html
Create an account
or login to join the discussion